The estimated Net Worth of Neena M Patil is at least $8.83 Million dollars as of 3 May 2024. Ms. Patil owns over 5,000 units of Jazz Pharmaceuticals plc stock worth over $3,850,807 and over the last 5 years she sold JAZZ stock worth over $1,771,409. In addition, she makes $3,205,780 as Senior Vice President and General Counsel at Jazz Pharmaceuticals plc.
Neena has made over 7 trades of the Jazz Pharmaceuticals plc stock since 2022, according to the Form 4 filled with the SEC. Most recently she sold 5,000 units of JAZZ stock worth $548,250 on 3 May 2024.
The largest trade she's ever made was selling 5,000 units of Jazz Pharmaceuticals plc stock on 3 May 2024 worth over $548,250. On average, Neena trades about 594 units every 32 days since 2019. As of 3 May 2024 she still owns at least 36,629 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Ms. Patil stock trades at the bottom of the page.
Neena M. Patil J.D. serves as Senior Vice President, General Counsel of the Company. Ms. Patil served as Senior Vice President, General Counsel and Corporate Secretary of Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company. Prior to that, from May 2008 to October 2016, Ms. Patil served in management positions at Novo Nordisk Inc., culminating in her role as Vice President for Legal Affairs and Associate General Counsel. Prior to 2008, she worked for several other global biopharmaceutical companies including Pfizer, GPC Biotech and Sanofi. Since 2015, she has been serving on the board of directors of Penn Medicine – Princeton Medical Center Foundation. Ms. Patil received a B.A. from Georgetown University and a J.D. and Master of Health Services Administration from the University of Michigan.
As the Senior Vice President and General Counsel of Jazz Pharmaceuticals plc, the total compensation of Neena Patil at Jazz Pharmaceuticals plc is $3,205,780. There are 3 executives at Jazz Pharmaceuticals plc getting paid more, with Bruce Cozadd having the highest compensation of $14,713,600.
Neena Patil is 45, she's been the Senior Vice President and General Counsel of Jazz Pharmaceuticals plc since 2019. There are 28 older and no younger executives at Jazz Pharmaceuticals plc. The oldest executive at Jazz Pharmaceuticals plc is Catherine Sohn, 67, who is the Independent Director.
Neena's mailing address filed with the SEC is 2005 MARKET STREET, SUITE 2100, PHILADELPHIA, PA, 19103.
Over the last 18 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright, and Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: